EUVIMEDEUVIMED entdecken
Open Access

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

Ying-Nai Wang, Heng-Huan Lee, Zhou Jiang, Li-Chuan Chan, Gabriel N Hortobagyi, Dihua Yu, Mien-Chie Hung

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.84592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Ying-Nai Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansAnimalsMiceFemaleRibonucleasesAdaptive ImmunityLymphocyte ActivationT-LymphocytesTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

T cell activityantitumor immunitybreast cancerribonuclease 1tumor microenvironmenttumor-infiltrating immune cells

Substanzen

Ribonucleases

Autor:innen und Institutionen

  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Graduate Institute of Biomedical Sciences, Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology, Cancer Biology and Precision Therapeutics Center, and Center for Molecular Medicine, China…
  • Department of Biotechnology, Asia University, Taichung, 413, Taiwan.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, Y. N., Lee, H. H., Jiang, Z., Chan, L. C., Hortobagyi, G. N., Yu, D., & Hung, M. C. (2023). Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.84592

Vancouver

Wang YN, Lee HH, Jiang Z, Chan LC, Hortobagyi GN, Yu D, et al. Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.84592

BibTeX
@article{Wang2023,
  author = {Wang, Ying-Nai and Lee, Heng-Huan and Jiang, Zhou and Chan, Li-Chuan and Hortobagyi, Gabriel N and Yu, Dihua and Hung, Mien-Chie},
  title = {Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.84592}
}
Kostenlos starten →